Statement | Pre-workshop n = 37 | Post-workshop n = 37 | Pre-post change | ||
---|---|---|---|---|---|
strongly agree % | somewhat agree % | strongly agree % | somewhat agree % | Wilcoxon signed rank test z statistic, p value, effect size | |
Person’s experience of CB should be used to guide treatment decisions independent of objective measures | 43.2 | 29.7 | 73.0 | 27.0 | 3.74, < 0.001, 0.6 |
People with CB are able to rate their own breathlessness intensity on a scale 0–10 | 10.8 | 48.6 | 21.6 | 59.5 | 2.95, 0.003, 0.5 |
People who experience CB would like to be asked about this symptom | 45.9 | 48.6 | 73.0 | 27.0 | 2.68, 0.007, 0.4 |
Serial measurements would be useful | 35.1 | 45.9 | 43.2 | 56.8 | 1.98, 0.05, 0.3 |
Breathlessness assessment by a scale should be part of ‘vital signs’ | 45.9 | 43.2 | 62.2 | 35.1 | 1.97, 0.05, 0.3 |
Judicious use of opioids can provide relief of CB | 21.6 | 37.8 | 27.0 | 54.1 | 1.65, 0.1, 0.3 |
Concern for respiratory depression limits use of opioids | 21.6 | 51.4 | 21.6 | 64.9 | 0.96, 0.34, 0.2 |
Relief of CB is a central goal of management | 51.4 | 43.2 | 64.9 | 27.0 | 0.89, 0.37, 0.1 |
CB is one of the main symptoms that cause patients to seek medical care. | 67.6 | 24.3 | 67.6 | 24.3 | 0.0, 1, 0 |